{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:16:48Z","timestamp":1791346608505,"version":"4.3.1"},"reference-count":11,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:title>This Policy Statement was retired July 2025.<\/jats:title>\n               <jats:p>Palivizumab was licensed in June 1998 by the Food and Drug Administration for the reduction of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV) in children at increased risk of severe disease. Since that time, the American Academy of Pediatrics has updated its guidance for the use of palivizumab 4 times as additional data became available to provide a better understanding of infants and young children at greatest risk of hospitalization attributable to RSV infection. The updated recommendations in this policy statement reflect new information regarding the seasonality of RSV circulation, palivizumab pharmacokinetics, the changing incidence of bronchiolitis hospitalizations, the effect of gestational age and other risk factors on RSV hospitalization rates, the mortality of children hospitalized with RSV infection, the effect of prophylaxis on wheezing, and palivizumab-resistant RSV isolates. This policy statement updates and replaces the recommendations found in the 2012 Red Book.<\/jats:p>","DOI":"10.1542\/peds.2014-1665","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T00:00:34Z","timestamp":1406592034000},"page":"415-420","source":"Crossref","is-referenced-by-count":529,"title":["Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection"],"prefix":"10.1542","volume":"134","author":[{"name":"COMMITTEE ON INFECTIOUS DISEASES AND BRONCHIOLITIS GUIDELINES COMMITTEE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Byington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Dele","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A.","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobeen H.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon E.","family":"Schutze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney E.","family":"Willoughby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis E.","family":"Zaoutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn L.","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan S.","family":"Lieberthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Cody","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Alverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Baley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Gadomski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Light","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar F.","family":"Maraqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eneida A.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran J.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Zorc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danette","family":"Stanko-Lopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinsi","family":"Hern\u00e1ndez-Cancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"issue":"17","key":"2025082909365742200_B1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.2012.476","article-title":"Choosing wisely: helping physicians and patients make smart decisions about their care.","volume":"307","author":"Cassel","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"2025082909365742200_B2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7326\/0003-4819-136-3-200202050-00012","article-title":"Medical professionalism in the new millennium: a physician charter.","volume":"136","author":"ABIM Foundation. American Board of Internal Medicine","year":"2002","journal-title":"Ann Intern Med"},{"issue":"14","key":"2025082909365742200_B3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMp1401335","article-title":"Promoting population health through financial stewardship.","volume":"370","author":"Ubel","year":"2014","journal-title":"N Engl J Med"},{"key":"2025082909365742200_B4","article-title":"Technical report: updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.","author":"American Academy of Pediatrics, Committee on Infectious Diseases and Bronchiolitis Guidelines Committee","year":"2014","journal-title":"Pediatrics"},{"key":"2025082909365742200_B5","first-page":"609","article-title":"Respiratory syncytial virus.","volume-title":"Red Book: 2012 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2012"},{"issue":"4","key":"2025082909365742200_B6","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1542\/peds.2006-2223","article-title":"Diagnosis and management of bronchiolitis.","volume":"118","author":"American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis","year":"2006","journal-title":"Pediatrics"},{"key":"2025082909365742200_B7","unstructured":"Synagis Package Insert. Gaithersburg, MD: MedImmune; April 2013. Available at: www.medimmune.com\/docs\/default-source\/pdfs\/prescribing-information-for-synagis.pdf. Accessed April 24, 2014"},{"issue":"6 pt 1","key":"2025082909365742200_B8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.","volume":"112","author":"American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"2025082909365742200_B9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","article-title":"Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV.","volume":"102","author":"American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn","year":"1998","journal-title":"Pediatrics"},{"key":"2025082909365742200_B10","first-page":"560","article-title":"Respiratory syncytial virus","volume-title":"Red Book: 2006 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2006"},{"issue":"6","key":"2025082909365742200_B11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: Policy statements\u2013Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.","volume":"124","author":"Committee on Infectious Diseases","year":"2009","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/2\/415\/1702868\/peds_2014-1665.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/2\/415\/1702868\/peds_2014-1665.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T13:37:06Z","timestamp":1756474626000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/2\/415\/33013\/Updated-Guidance-for-Palivizumab-Prophylaxis-Among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-1665","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}